Neuronal Mechanisms underlying sex differences in dystonia
肌张力障碍性别差异背后的神经机制
基本信息
- 批准号:10784385
- 负责人:
- 金额:$ 5.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-15 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAffinity ChromatographyAnimal ModelBasal GangliaBiologicalClinical Trials DesignCodeCorpus striatum structureDataDiagnosisDiseaseDopa-Responsive DystoniaDopamineDystoniaEstradiolEstrogensEstrous CycleEstrusFemaleFibrinogenFoundationsFunctional ImagingFunctional disorderGenesGlobus PallidusHormonalHumanHyperactivityImageKnock-in MouseKnowledgeMediatingMicroelectrodesMolecularMolecular ProfilingMovementMovement DisordersMusMuscle ContractionMutationNeuronsOvarian hormonePathogenesisPathway interactionsPatientsPatternPhasePhysiologicalPhysiologyPlayPostureProcessPropertyRibosomesRisk FactorsRoleSample SizeSex BiasSex DifferencesSmooth MuscleStructureSubstantia nigra structureTestingTimeTissuesTranslatingbiological sexcell typeepidemiology studyexperimental studyimaging studyin vivomalemouse modelneuralneuroregulationneurotransmissionprototypesegregationsexsex cyclesexual dimorphismtranslatome
项目摘要
Dystonia is characterized by involuntary muscle contractions that cause twisting movements and postures. Many
dystonias are more common in females than in males yet the mechanisms underlying these sex differences are
largely unexplored. Basal ganglia dysfunction is consistently implicated across many forms of dystonia. The
major input structure of the basal ganglia is the striatum where estrogen exerts neuromodulatory effects. In fact,
the physiological properties of striatal spiny projection neurons (SPNs) are known to vary depending on biological
sex and estrous cycle phase. Direct pathway SPNs (dSPNs) project to the internal globus pallidus to promote
movement. Indirect pathway SPNs (iSPNs) project to the external globus pallidus to inhibit movement. Although
dSPNs and iSPNs are segregated into separate pathways, they act in concert to mediate and refine movements.
In dystonia patients, this coordinated activity is disrupted as functional imaging studies and microelectrode
recordings suggest that both dSPNs and iSPNs are dysfunctional. However, the mechanisms underlying both
SPN pathophysiology and sex differences in dystonia remain unknown.
Several challenges have stymied our ability to understand the pathophysiology and the relationship to biological
sex in dystonia. First, information obtained by studying patients is, by necessity, quite limited. Second, despite
the epidemiological studies demonstrating sex differences in the expression of dystonia, sex as a biological
variable is rarely incorporated into studies examining mechanisms underlying dystonia in patients or animal
models. Third, we lack foundational studies in healthy controls that disentangle the effects of biological sex on
striatal cell types. Indeed, studies characterizing sex differences in normal striatal physiology have not
distinguished between SPN subtypes, while studies examining the molecular properties of dSPNs and iSPNs
have not examined sex as a biological variable. This proposal addresses these gaps in knowledge.
Our understanding of the pathophysiology of dystonia has also been hampered by the lack of animal models
with sexually dimorphic dystonia caused by striatal dysfunction. To address this gap, we created a knockin
mouse model of DOPA-responsive dystonia (DRD). In patients, DRD is female predominant, like many forms of
dystonia in humans. DRD is also a prototype disorder for understanding basal ganglia dysfunction in dystonia In
DRD mice, the striatum plays a central role in mediating dystonia and dSPN and iSPN signaling is disrupted.
Further, the presentation of dystonia in DRD mice is significantly different between males and females and the
dystonia fluctuates with the estrus cycle. Thus, for the first time, it is possible to elucidate the neural code of
dystonia in the context of the mechanisms that drive the sex differences. The Specific Aims are: 1. to determine
the role of ovarian hormones in the expression of dystonia. 2. to identify the molecular signature of dystonia in
dSPNs and iSPNs in male and female DRD mice. 3. to define the pattern of dSPN and iSPN activity underlying
dystonia in male and female DRD mice.
肌张力障碍的特征是不随意的肌肉收缩,引起扭曲的运动和姿势。许多
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ELLEN J. HESS其他文献
ELLEN J. HESS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ELLEN J. HESS', 18)}}的其他基金
Neuronal Mechanisms underlying sex differences in dystonia
肌张力障碍性别差异背后的神经机制
- 批准号:
10701752 - 财政年份:2022
- 资助金额:
$ 5.95万 - 项目类别:
Neuronal Mechanisms underlying sex differences in dystonia
肌张力障碍性别差异背后的神经机制
- 批准号:
10518475 - 财政年份:2022
- 资助金额:
$ 5.95万 - 项目类别:
Striatal cell-type specific molecular adaptations in a mouse model of dystonia
肌张力障碍小鼠模型中纹状体细胞类型特异性分子适应
- 批准号:
10057917 - 财政年份:2020
- 资助金额:
$ 5.95万 - 项目类别:
Dopamine neurotransmission in a model of DOPA-responsive dystonia
多巴反应性肌张力障碍模型中的多巴胺神经传递
- 批准号:
9481589 - 财政年份:2017
- 资助金额:
$ 5.95万 - 项目类别:
Dopamine neurotransmission in a model of DOPA-responsive dystonia
多巴反应性肌张力障碍模型中的多巴胺神经传递
- 批准号:
9203641 - 财政年份:2015
- 资助金额:
$ 5.95万 - 项目类别:
Dopamine neurotransmission in a model of DOPA-responsive dystonia
多巴反应性肌张力障碍模型中的多巴胺神经传递
- 批准号:
8887950 - 财政年份:2015
- 资助金额:
$ 5.95万 - 项目类别:
Cerebellar stimulation for the treatment of dystonia: preclinical studies
小脑刺激治疗肌张力障碍:临床前研究
- 批准号:
8269318 - 财政年份:2012
- 资助金额:
$ 5.95万 - 项目类别:
Cerebellar stimulation for the treatment of dystonia: preclinical studies
小脑刺激治疗肌张力障碍:临床前研究
- 批准号:
8458057 - 财政年份:2012
- 资助金额:
$ 5.95万 - 项目类别:
Generation of a mouse model of L-DOPA-responsive dystonia (DRD)
L-DOPA 反应性肌张力障碍 (DRD) 小鼠模型的生成
- 批准号:
7765651 - 财政年份:2007
- 资助金额:
$ 5.95万 - 项目类别:
Generation of a mouse model of episodic ataxia type 2 (EA2)
2 型发作性共济失调 (EA2) 小鼠模型的生成
- 批准号:
7313608 - 财政年份:2007
- 资助金额:
$ 5.95万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 5.95万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 5.95万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 5.95万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 5.95万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 5.95万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 5.95万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 5.95万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 5.95万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 5.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 5.95万 - 项目类别:
Collaborative Research and Development Grants














{{item.name}}会员




